Limiting Access to Psychiatric Services Can Increase Total Health Care Costs

Journal of Clinical Psychiatry

Volumn 64, Issue SUPPL. 17, 2003, Pages 23-28

  Horn, Susan D ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL PRACTICE; CONFERENCE PAPER; DEPRESSION; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HEALTH CARE UTILIZATION; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MAJOR DEPRESSION; MANAGED CARE; MENTAL DISEASE; MENTAL HEALTH SERVICE; NEUROSIS; PATIENT CARE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; TREATMENT PLANNING;

ANTIPSYCHOTIC AGENTS; COST CONTROL; DIAGNOSTIC ERRORS; DRUG UTILIZATION; HEALTH CARE COSTS; HEALTH MAINTENANCE ORGANIZATIONS; HEALTH SERVICES ACCESSIBILITY; HUMANS; MENTAL DISORDERS; MENTAL HEALTH SERVICES; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; PSYCHIATRY; RANDOMIZED CONTROLLED TRIALS; REFERRAL AND CONSULTATION; UNITED STATES;

EID: 0346622390     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. National Institute of Mental Health. The numbers count: mental disorders in America. Bethesda, Md: US Dept of Health and Human Services, National Institute of Mental Health; 2003
2. Greenberg PE, Stiglin LE, Finkelstein SN, et al. The economic burden of depression in 1990. J Clin Psychiatry 1993;54:405-418
3. Carlson G. What is a health maintenance organization? Available at: http://www.outreach.missouri.edu/hes/fmhlth/whatishmo.htm. Accessed July 11, 2003
4. Horn SD, Sharkey PD, Tracy DM, et al. Intended and unintended consequences of HMO cost-containment strategies: results from the Managed Care Outcomes Project. Am J Managed Care 1996;2:253-264
5. Horn SD. Overcoming obstacles to effective treatment: use of clinical practice improvement methodology. J Clin Psychiatry 1997;58(suppl 1):15-19
6. Horn SD, Sharkey PD, Phillips-Harris C. Formulary limitations and the elderly: results from the Managed Care Outcomes Project. Am J Managed Care 1998;4:1105-1113
7. Lohr KJ, Brook RH, Kamberg C, et al. Rand health insurance experiment. Med Care 1986;24:S72-S87
8. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-1892
9. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000;342:1878-1886
10. Ioannidis JPA, Haidich AB, Pappa M, et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 2001;286:821-830
11. Bartels SJ, Horn SD, Sharkey PD, et al. Treatment of depression in older primary care patients in health maintenance organizations. Int J Psychiatry Med 1997;27:215-231
12. Horn SD, Sharkey PD, Gassaway J. Managed Care Outcomes Project: study design, baseline patient characteristics, and outcome measures. Am J Managed Care 1996;2:237-247
13. Nurnberg HG, Thompson PM, Hensley PL. Antidepressant medication change in a clinical treatment setting: a comparison of the effectiveness of selective serotonin reuptake inhibitors. J Clin Psychiatry 1999;60:574-579
14. Horn SD, Bender SA, Bergstrom N, et al. Description of the National Pressure Ulcer Long-Term Care Study. J Am Geriatr Soc 2002;50:1816-1825
15. Hensley PL, Nurnberg HG. Formulary restrictions of selective serotonin reuptake inhibitors for depression: potential piffalls. Pharmacoeconomics 2001;19:973-982
16. Popovian R, Johnson KA, Nichols MB, et al. The impact of pharmaceutical capitation to primary medical groups on the health care expenditures of Medicare HMO enrollees. J Managed Care Pharm 1999;5:414-419
17. Soumerai SB, Ross-Degnan D, Avorn J, et al. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med 1991;325:1072-1077
18. Soumerai SB, McLaughlin TJ, Ross-Degnan D, et al. Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med 1994;331:650-655
19. Horn SD, ed. Clinical Practice Improvement Methodology: Implementation and Evaluation. New York, NY: Faulkner & Gray; 1997
20. Willson DF, Horn SD, Hendley JO, et al. The effect of practice variation on resource utilization in infants hospitalized for viral lower respiratory illness (VLRI), Pediatrics 2001;108:851-855
21. Johnson JA, Friesen E, Reassessing the relevance of pharmacoeconomic analyses in formulary decisions. Pharmacoeconomics 1998;13:479-485
22. Guze BH. Selective serotonin reuptake inhibitors: assessment for formulary inclusion. Pharmacoeconomics 1996;9:430-442